secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2026-06-18T13:12:19+00:00
Accession:  0001193125-26-275086
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare EVP & Chief Clinical Officer Michael Cuffe to step down Aug 31, 2026
--------------------------------------------------------------------------------

- Dr. Michael Cuffe to step down as EVP and Chief Clinical Officer effective August 31, 2026.
- He will continue in a transitional role with the company until February 2027.
- Eligible for benefits under executive severance policy and applicable incentive plans.
- No successor has been named at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312526275086/0001193125-26-275086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312526275086/d163825d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-275086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer